Skip Navigation
American College of Physicians Logo
  • Subscribe
  • Submit a Manuscript
  • Sign In
    Sign in below to access your subscription for full content
    INDIVIDUAL SIGN IN
    Sign In|Set Up Account
    You will be directed to acponline.org to register and create your Annals account
    INSTITUTIONAL SIGN IN
    Open Athens|Shibboleth|Log In
    Annals of Internal Medicine
    SUBSCRIBE
    Subscribe to Annals of Internal Medicine.
    You will be directed to acponline.org to complete your purchase.
Annals of Internal Medicine Logo Menu
  • Latest
  • Issues
  • Channels
  • CME/MOC
  • In the Clinic
  • Journal Club
  • Web Exclusives
  • Author Info
Advanced Search
  • ‹ PREV ARTICLE
  • This Issue
  • NEXT ARTICLE ›
Summaries for Patients |5 August 2003

Oral Administration of an Antibiotic (Norfloxacin) May Help Treat the Cardiac and Circulatory Complications of Liver Failure

Article, Author, and Disclosure Information
Author, Article, and Disclosure Information

  • The summary below is from the full report titled The Effect of Selective Intestinal Decontamination on the Hyperdynamic Circulatory State in Cirrhosis. A Randomized Trial. It is in the 5 August 2003 issue of Annals of Internal Medicine (volume 139, pages 186-193). The authors are B. Rasaratnam, D. Kaye, G. Jennings, F. Dudley, and J. Chin-Dusting.


Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians.
×
  • ‹ PREV ARTICLE
  • This Issue
  • NEXT ARTICLE ›
Jump To
  • Full Article
  • FULL ARTICLE
  • FULL ARTICLE
    • What is the problem and what is known about it so far?
    • Why did the researchers do this particular study?
    • Who was studied?
    • How was the study done?
    • What did the researchers find?
    • What were the limitations of the study?
    • What are the implications of the study?
  • Figures
  • Tables
  • Supplements
  • Audio/Video
  • Summary for Patients
  • Clinical Slide Sets
  • CME / MOC
  • Comments
  • Twitter Link
  • Facebook Link
  • Email Link
More
  • LinkedIn Link

What is the problem and what is known about it so far?

Advanced liver failure affects many organs in addition to the liver. For example, when the liver fails, the circulatory system reacts by relaxing the muscular coating that surrounds blood vessels. This allows blood vessels to open wider, causing blood to flow more rapidly through the vessels. As a result, to maintain blood pressure at safe levels, the heart must beat faster and the amount of blood pumped by the heart (the cardiac output) must increase. This altered condition of the circulatory system, known as a hyperdynamic circulatory state, puts a dangerous strain on the heart and may cause death. Certain types of bacteria cause this problem when they invade the bloodstream. Doctors have speculated that the circulatory changes that accompany liver failure occur because the liver, which normally removes bacteria that leak into the bloodstream from the bowel, can no longer perform this function. Until now, no effective treatment has been available for the hyperdynamic circulatory state that accompanies liver failure.

Why did the researchers do this particular study?

To find out whether oral administration of norfloxacin (an antibiotic that kills bacteria in the bowel) could block the effects of liver failure on the circulatory system.

Who was studied?

14 men with alcohol-related liver disease (cirrhosis) who were compared to 14 healthy male volunteers of the same age.

How was the study done?

Participants with cirrhosis were randomly assigned to receive either norfloxacin capsules or placebo capsules (that looked exactly like norfloxacin) for 28 days. Neither the patient nor the doctor knew which capsule was being taken. After 28 days of treatment, the capsules were switched; the participants who had taken norfloxacin were given placebo and those who had taken placebo were given norfloxacin for another 28 days. At the end of each treatment period, a blood sample was drawn in participants with cirrhosis to test for the presence of bacterial products in the bloodstream (endotoxins) and for the level of natural chemicals that maintain blood pressure. In addition, the researchers measured cardiac output and kidney function. Normal volunteers underwent studies only once and received no medication.

What did the researchers find?

Measurements in normal participants were compared with the results in cirrhotic participants who took norfloxacin or placebo. When cirrhotic persons took norfloxacin capsules, blood pressure improved, blood flow through the vessels became more normal, and cardiac output decreased slightly (but not significantly). Norfloxacin had no effect on how well the kidneys were working.

What were the limitations of the study?

The researchers could not confirm the exact way that norfloxacin caused the circulatory changes that they observed. Additional factors must be involved in producing the hyperdynamic circulatory state because norfloxacin did not completely block its manifestations.

What are the implications of the study?

Oral administration of norfloxacin may be helpful in treating a dangerous side effect of liver failure.

This feature is available only to Registered Users

Subscribe/Learn More
Submit a Comment

0 Comments

PDF
Not Available
Citations
Citation

Oral Administration of an Antibiotic (Norfloxacin) May Help Treat the Cardiac and Circulatory Complications of Liver Failure. Ann Intern Med. 2003;139:I–62. doi: https://doi.org/10.7326/0003-4819-139-3-200308050-00004

Download citation file:

  • Ris (Zotero)
  • EndNote
  • BibTex
  • Medlars
  • ProCite
  • RefWorks
  • Reference Manager

© 2020

×
Permissions

Published: Ann Intern Med. 2003;139(3):I-62.

DOI: 10.7326/0003-4819-139-3-200308050-00004

©
2003 American College of Physicians
0 Citations
Advertisement

See Also
The Effect of Selective Intestinal Decontamination on the Hyperdynamic Circulatory State in Cirrhosis: A Randomized Trial
View MoreView Less

Related Articles
Treatment for Bacterial Overgrowth in the Irritable Bowel Syndrome
Annals of Internal Medicine; 145 (8): 626-628
Increasing Incidence of Multiply Recurrent Clostridium difficile Infection in the United States: A Cohort Study
Annals of Internal Medicine; 167 (3): 152-158
Antibiotic Prescribing for Respiratory Tract Infections and Encounter Length: An Observational Study of Telemedicine
Annals of Internal Medicine; 170 (4): 275-277
Annals for Educators - 6 November 2018
Annals of Internal Medicine; 169 (9): ED9
View MoreView Less

Journal Club
Procalcitonin-guided antibiotic prescribing did not reduce antibiotic use in suspected LRTI in the ED
Annals of Internal Medicine; 169 (8): JC39
Review: Procalcitonin-guided starting and stopping of antibiotics in acute respiratory infections reduces mortality
Annals of Internal Medicine; 168 (4): JC19
Review: In primary care, CRP testing, shared decision making, and procalcitonin reduce antibiotic prescribing for ARI
Annals of Internal Medicine; 168 (2): JC11
Guided early deescalation of antiplatelet treatment was noninferior to usual prasugrel care in PCI-treated ACS
Annals of Internal Medicine; 167 (12): JC69
View MoreView Less

Related Point of Care
Clostridioides difficile Infection
Annals of Internal Medicine; 169 (7): ITC49-ITC64
Community-Acquired Pneumonia
Annals of Internal Medicine; 163 (7): ITC1
Community-Acquired Pneumonia
Annals of Internal Medicine; 151 (7): ITC4-1
Palliative Care
Annals of Internal Medicine; 168 (5): ITC33-ITC48
View MoreView Less

Related Topics
Cardiology
Gastroenterology/Hepatology
Liver Disease

Cardiology, Gastroenterology/Hepatology, Liver Disease.

PubMed Articles
Use of home negative pressure wound therapy in peripheral artery disease and diabetic limb salvage.
Int Wound J 2020.
Dissemination and conservation of cadmium and arsenic resistance determinants in Listeria and other Gram-positive bacteria.
Mol Microbiol 2020.
View More

Results provided by: PubMed

Advertisement
CME/MOC Activity Requires Users to be Registered and Logged In.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
Annals of Internal Medicine
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
The Comments Feature Requires Users to be Registered and Logged In.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
Annals of Internal Medicine
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
link to top

Content

  • Home
  • Latest
  • Issues
  • Channels
  • CME/MOC
  • In the Clinic
  • Journal Club
  • Web Exclusives

Information For

  • Author Info
  • Reviewers
  • Press
  • Readers
  • Institutions / Libraries / Agencies
  • Advertisers

Services

  • Subscribe
  • Renew
  • Alerts
  • Current Issue RSS
  • Latest RSS
  • In the Clinic RSS
  • Reprints & Permissions
  • Contact Us
  • Help
  • About Annals
  • About Mobile
  • Patient Information
  • Teaching Tools
  • Annals in the News
  • Share Your Feedback

Awards and Cover

  • Personae (Cover Photo)
  • Junior Investigator Awards
  • Poetry Prize

Other Resources

  • ACP Online
  • Career Connection
  • ACP Advocate Blog
  • ACP Journal Wise

Follow Annals On

  • Twitter Link
  • Facebook Link
acp link acp
silverchair link silverchair

Copyright © 2020 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
INSTITUTIONAL SIGN IN
Open Athens|Shibboleth|Log In
Annals of Internal Medicine
PURCHASE OPTIONS
Buy This Article|Subscribe
You will be redirected to acponline.org to sign-in to Annals to complete your purchase.
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
Annals of Internal Medicine
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×